In this issue of JAMA Psychiatry, Heil et al1 report a randomized clinical trial to evaluate the efficacy and cost benefits of interventions to increase prescription contraceptive use among women with opioid use disorder (OUD) at risk for unintended pregnancy. The study found that verified contraception use was highest and unintended pregnancy rates were lowest among women randomized to receive 2 interventions: onsite contraceptive services plus a financial incentive to return for follow-up visits.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Lyerly AD. Beyond Voluntariness—Ethics and Incentives for Contraception. JAMA Psychiatry. Published online July 14, 2021. doi:10.1001/jamapsychiatry.2021.1284
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: